| Literature DB >> 32552709 |
Xuanye Bi1, Chengzhi Yang1, Yunhu Song1, Jiansong Yuan1, Jingang Cui1, Fenghuan Hu1, Shubin Qiao2.
Abstract
BACKGROUND: To investigate the relationship between fragmented QRS (fQRS) quantified by a new method and myocardial fibrosis (MF) and the diagnostic value of quantitative fQRS (Q-fQRS) to detect MF in hypertrophic obstructive cardiomyopathy (HOCM) patients based on histological validation.Entities:
Keywords: Hypertrophic obstructive cardiomyopathy; Myocadial fibrosis; Quantitative fragmented QRS
Year: 2020 PMID: 32552709 PMCID: PMC7302347 DOI: 10.1186/s12872-020-01590-2
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Fig. 3Comparison of CVF in control subjects and HOCM patients and in fQRS(+) and fQRS(−) groups. HOCM patients had higher CVF value than controls a (P = 0.015). CVF is higher in patients with fQRS than those without fQRS b (P < 0.001) .Myocardial fibrosis, stained in blue by Masson’s trichrome staining c, d and e. The left panel correspond to mycardial fibrosis in controls c, the middle and right panel correspond to mild and severe myocardial fibrosis in HOCM patients d and e.Magnification×200
Fig. 1Example of fagmented QRS. The different morphologies of fQRS are shown in this figure; notching of the R wave in leads II, III, and aVF, and notching in nadir of the S wave in leads I, aVL. The quantitative fQRS (Q-fQRS) counting is indicated by red arrows. Each arrow represents a positive or negative deflflection counted as fractionated signal. Lead I, AVL, II, III, AVF have a Q-fQRS count being 4, 4,3, 4 and 5, respectively. The total Q-fQRS count in this figure add up to 20
Baseline characteristics of 49 patients with HCM
| All patients | Patients with HOCM | |||
|---|---|---|---|---|
| ( | With fQRS | Without fQRS | ||
| ( | ( | |||
| Age,years | 46.1 ± 14.4 | 43.7 ± 15.6 | 49 ± 12.3 | 0.129 |
| Male,% | 43 (62.3) | 22 (57.9) | 21 (67.7) | 0.401 |
| Dyspnea,% | 61 (88.4) | 34 (89.5) | 27 (87.1) | 1 |
| NYHA III/IV,% | 22 (31.9) | 13 (34.2) | 9 (29) | 0.646 |
| History of syncope,% | 19 (27.5) | 13 (34.2) | 6 (19.4) | 0.169 |
| History of hypertension,% | 15 (21.7) | 6 (15.8) | 9 (29) | 0.185 |
| History of diabetes mellitus,% | 6 (8.7) | 4 (10.5) | 2 (6.5) | 0.867 |
| Family history of HCM or SCD,% | 5 (7.2) | 2 (5.3) | 3 (9.7) | 0.813 |
| NSVT,% | 12 (17.4) | 7 (18.4) | 5 (16.1) | 0.803 |
| AF,% | 9 (13) | 5 (13.2) | 4 (12.9) | 1 |
| Bundle branch block,% | 4 (5.8) | 2 (5.3) | 2 (6.5) | 1 |
| ICD,% | 0 (0) | 0 (0) | 0 (0) | 1 |
| SAM,% | 68 (98.6) | 38 (100) | 30 (96.8) | 0.449 |
| Mitral regurgitation | 2 (1–2) | 2 (1–3) | 2 (1–2) | 0.373 |
| Calcium antagonist,% | 25 (36.2) | 11 (28.9) | 14 (45.2) | 0.163 |
| Beta blocker,% | 51 (73.9) | 33 (86.8) | 18 (58.1) | 0.007 |
| ACEI/ARB,% | 2 (2.9) | 0 (0) | 2 (6.5) | 0.204 |
| Diuretics,% | 24 (34.8) | 11 (28.9) | 13 (41.9) | 0.26 |
| CMR | ||||
| Septal wall thickness,mm | 25 (21–29) | 26 (21.8–29) | 24 (19–29) | 0.637 |
| Left atrium diameter,mm | 41.8 ± 7.9 | 42 ± 8.4 | 41.5 ± 7.3 | 0.802 |
| LV end-diastolic diameter,mm | 45.6 ± 4.2 | 46.1 ± 4 | 44.9 ± 4.3 | 0.236 |
| LVMI,g/m2 | 88.9 (73.3–117.4) | 91.5 (77.2–133.5) | 83 (66.9–110) | 0.385 |
| LVEF,% | 64.8 ± 9.6 | 64.1 ± 9.6 | 65.8 ± 9.8 | 0.47 |
| LVEDVI,ml/m2 | 83.7 ± 20.4 | 87.7 ± 23.2 | 78.7 ± 15.4 | 0.069 |
| LVESVI,ml/m2 | 28.7 (21.8–36.3) | 31.7 (23.7–39.4) | 25.9 (19.9–30.9) | 0.054 |
| LGE at 2SD,% | 27.5 (22.4–38.2) | 28 (22.5–39.9) | 26.9 (19–37.2) | 0.403 |
| LGE at 4SD,% | 12.8 (6.9–19.1) | 14.4 (9.5–21.9) | 11.9 (5.8–16.7) | 0.067 |
| LGE at 6SD,% | 6.2 (1.9–8.7) | 6.7 (3.9–10.8) | 4.2 (1.6–7.5) | 0.04 |
| LGE at 8SD,% | 2.4 (0.45–4.65) | 3.2 (0.62–5.9) | 1.9 (0.33–3.4) | 0.057 |
| BSA,m2 | 1.8 (1.6–1.9) | 1.7 (1.6–1.9) | 1.8 (1.7–1.9) | 0.05 |
Data are presented as the mean value SD (p values for 2-sided Student’s t test) or median and interquartile (p values for Mann-Whitney test) or percentage of patients (p values for chi-square test). Volumes are indexed to body surface area. ACEI angiotensin-converting enzyme inhibitor, AF atrial fibrillation, ARB angiotensin receptor blocker, BSA body surface area, ICD implantable cardioverter-defibrillator, HCM hypertrophic cardiomyopathy, LGE late gadolinium enhancement, LVEDVI Left ventricle end diastolic volume index, LVEF left ventricular ejection fraction, LVESVI Left ventricle end systolic volume index, LVMI left ventricle mass index, NYHA New York Heart Association, NSVT non-sustained ventricular tachycardia, SAM systolic anterior motion, SCD sudden cardiac death,SD standard deviation
Fig. 2Bland-Altman analysis a and correlation b of CVF between 2 observers
Fig. 4Spearman’s correlation analysis of CVF and clinic parameters. Significance was noted between CVF and LGE at 6SD a (P < 0.001), the number of lead with fQRS b (P < 0.001) and Q-fQRS c (P < 0.001)
Predictors of CVF in the HOCM Patients (Unadjusted and Multivariate Regression Analysis)
| Variable | Univariate | Multivariate | ||
|---|---|---|---|---|
| Age | −0.043 ± 0.044 | 0.340 | −0.002 ± 0.036 | 0.953 |
| Sex | −1.470 ± 1.299 | 0.262 | −1.246 ± 1.060 | 0.244 |
| BSA | −6.015 ± 3.341 | 0.076 | ||
| Q-fQRS | 0.412 ± 0.052 | < 0.001 | 0.408 ± 0.067 | < 0.001 |
| LGE at 6 SD | 0.415 ± 0.113 | 0.001 | ||
BSA body surface area, CVF collagen volume fraction, LGE late gadolinium, Q-fQRS quantitative fragmented QRS, SD standard deviation;
Predictive ability of each examination to discriminate HOCM patients with high CVF from those with normal CVF
| AUC | 95%CI | Cutoff value | Sensitivity,% | Specificity,% | PPV,% | NPV,% | Accuracy,% | |
|---|---|---|---|---|---|---|---|---|
| Q-fQRS | 0.747 | 0.611–0.838 | 7 | 66.7 | 76.7 | 78.8 | 63.9 | 71 |
| The numer of leads with fQRS | 0.729 | 0.594–0.825 | 3 | 59 | 80 | 79.3 | 60 | 68.1 |
| LGE at 6SD | 0.741 | 0.617–0.843 | 6.22 | 68.6 | 72.4 | 75 | 65.6 | 70.3 |
AUC area under curve, CI confidence interval, CVF collagen volume fraction, NPV negative predictive value, LGE late gadolinium, PPV positive predictive value, Q-fQRS quantitative fragmented QRS, SD standard deviation;
Fig. 5Receiver operating analysis showing the diagnostic value for LGE at 6SD, the number of lead with fQRS and Q-fQRS to identify HOCM patients with high CVF